Identifiability of the joint distribution of age and tumor size at detection in the presence of screening

Mathematical Biosciences

Volumn 208, Issue 2, 2007, Pages 644-657

  Hanin, Leonid ^a   Yakovlev, Andrei ^b  

^a Nucl Eng Idaho State University   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Cancer detection; Cancer natural history; Cancer screening; Model identifiability; Tumor latency; Tumor size

Indexed keywords

DIAGNOSIS; PARAMETER ESTIMATION; POPULATION DYNAMICS; STOCHASTIC MODELS; TUMORS;

CANCER DETECTION; CANCER NATURAL HISTORY; CANCER SCREENING; MODEL IDENTIFIABILITY; TUMOR LATENCY; TUMOR SIZE;

ONCOLOGY;

AGE STRUCTURE; CANCER; COHORT ANALYSIS; DETECTION METHOD; DISEASE INCIDENCE; IDENTIFICATION METHOD; MORTALITY; STOCHASTICITY; TUMOR;

AGE DISTRIBUTION; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER SCREENING; MATHEMATICAL COMPUTING; TUMOR VOLUME;

AGE DISTRIBUTION; HUMANS; MASS SCREENING; MATHEMATICS; MODELS, BIOLOGICAL; NEOPLASMS; STOCHASTIC PROCESSES;

EID: 34547130857     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mbs.2006.12.004     Document Type: Article

References (47)

1. Hanin L. Identification problem for stochastic models with application to carcinogenesis, cancer detection and radiation biology. Discrete Dyn. Nat. Soc. 7 (2002) 177
2. Albert A., Gertman P.M., and Louis T.A. Screening for the early detection of cancer. I. The temporal history of a progressive disease state. Math. Biosci. 40 (1978) 1
3. Albert A., Gertman P.M., Louis T.A., and Liu S.I. Screening for the early detection of cancer. II. The impact of the screening on the natural history of the disease. Math. Biosci. 40 (1978) 61
4. Blumenson L.E. Detection of disease with periodic screening: transient analysis and application to mammography examination. Math. Biosci. 33 (1977) 73
5. Blumenson L.E., and Bross I.D.J. A mathematical analysis of the growth and spread of breast cancer. Biometrics 22 (1969) 95
6. Brookmeyer R., and Day N. Two-stage model for the analysis of cancer screening data. Biometrics 43 (1987) 657
7. Day N.E., and Walter S.D. Simplified models of screening for chronic disease. Estimation procedures from mass screening programs. Biometrics 40 (1984) 1
8. Duffy S.W., Chen H.H., Tabar L., and Day N.E. Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Stat. Med. 14 (1995) 1531
9. Flehinger B.J., and Kimmel M. Screening for cancer in relation to the natural history of the disease. In: Axelrod D.E., and Kimmel M. (Eds). Mathematical Population Dynamics (1991), Marcel Dekker, New York 383
10. Hu P., and Zelen M. Planning clinical trials to evaluate early detection programmes. Biometrika 84 (1997) 817
11. Lee S.J., and Zelen M. Scheduling periodic examinations for the early detection of disease: applications to breast cancer. J. Am. Stat. Assoc. 93 (1998) 1271
12. Louis T., Albert A., and Heghinian S. Screening for the early detection of cancer. III. Estimation of disease natural history. Math. Biosci. 40 (1978) 111
13. Parmigiani G. On optimal screening ages. J. Am. Stat. Ass. 88 (1993) 622
14. Parmigiani G. Timing medical examinations via intensity functions. Biometrika 84 (1997) 803
15. Pinsky P.F. Estimation and prediction for cancer screening models using deconvolution and smoothing. Biometrics 57 (2001) 389
16. Prorok P.C. The theory of periodic screening I: Lead time and proportion detected. Adv. Appl. Probab. 8 (1976) 127
17. Prorok P.C. The theory of periodic screening II: Doubly bounded recurrence times and mean lead time and detection probability estimation. Adv. Appl. Probab. 8 (1976) 460
18. Shen Y., and Zelen M. Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding. Biometrika 86 (1999) 503
19. Shen Y., and Zelen M. Screening sensitivity and sojourn time from breast cancer early detection clinical trials: mammograms and physical examinations. J. Clin. Oncol. 19 (2001) 3490
20. Schwartz M. An analysis of the benefits of serial screening for breast cancer based upon a mathematical model of the disease. Cancer 41 (1978) 1550
21. Schwartz M. A mathematical model used to analyse breast cancer screening strategies. Oper. Res. 26 (1978) 937
22. Tsodikov A.D., and Yakovlev A.Y. On the optimal policies of cancer screening. Math. Biosci. 107 (1991) 21
23. Tsodikov A.D., Asselain B., Fourquet A., Hoang T., and Yakovlev A.Y. Discrete strategies of cancer post-treatment surveillance. Estimation and optimization problems. Biometrics 51 (1995) 437
24. Walter S.D., and Day N.E. Estimation of the duration of a preclinical state using screening data. Am. J. Epidemiol. 118 (1983) 865
25. Yakovlev A.Y., and Tsodikov A.D. Stochastic Models of Tumor Latency and their Biostatistical Applications (1996), World Scientific Publishers, Singapore
26. Zelen M. Optimal scheduling of examinations for the early detection of disease. Biometrika 80 (1993) 279
27. Zelen M., and Feinleib M. On the theory of screening for chronic disease. Biometrika 56 (1969) 601
28. Hanin L.G., and Yakovlev A.Y. Multivariate distributions of clinical covariates at the time of cancer detection. Stat. Methods Med. Res. 13 (2004) 457
29. Bartoszyński R., Edler L., Hanin L., Kopp-Schneider A., Pavlova L., Tsodikov A., Zorin A., and Yakovlev A. Modeling cancer detection: tumor size as a source of information on unobservable stages of carcinogenesis. Math. Biosci. 171 (2001) 113
30. Hanin L.G., Tsodikov A.D., and Yakovlev A.Y. Optimal schedules of cancer surveillance and tumor size at detection. Math. Comp. Model. 33 (2001) 1419
31. L.G. Hanin, A. Miller, A.V. Zorin, A.Y. Yakovlev, The University of Rochester model of breast cancer detection and survival, Journal of the National Cancer Institute, Monograph 36, The Impact of Mammography and Adjuvant Therapy on U.S. Breast Cancer Mortality (1975-2000): Collective Results from the Cancer Intervention and Surveillance Modeling Network, pp. 86-95.
32. Berry D.A., Cronin K.A., Plevritis S.K., Fryback D.G., Clarke L., Zelen M., Mandelblatt J., Yakovlev A.Y., Habbema J.D.F., and Feuer E.J. Effect of screening and adjuvant therapy on mortality from breast cancer. N. Engl. J. Med. 353 (2005) 1784
33. Moolgavkar S.H., and Venzon D.J. Two event model for carcinogenesis: incidence curves for childhood and adult tumors. Math. Biosci. 47 (1979) 55
34. Moolgavkar S.H., and Knudson A.G. Mutation and cancer: a model for human carcinogenesis. J. Natl. Cancer Inst. 66 (1981) 1037
35. Moolgavkar S.H., and Luebeck E.G. Two-event model for carcinogenesis: biological, mathematical and statistical considerations. Risk Anal. 10 (1990) 323
36. Heidenreich W.F. On the parameters of the clonal expansion model. Radiat. Environ. Biophys. 35 (1996) 127
37. Hanin L.G., and Yakovlev A.Y. A nonidentifiability aspect of the two-stage model of carcinogenesis. Risk Anal. 16 (1996) 711
38. Heidenreich W.F., Luebeck E.G., and Moolgavkar S.H. Some properties of the hazard function of the two-mutation clonal expansion model. Risk Anal. 17 (1997) 391
39. Gregori G., Hanin L., Luebeck G., Moolgavkar S., and Yakovlev A. Testing goodness of fit with stochastic models of carcinogenesis. Math. Biosci. 175 (2001) 13
40. A.V. Zorin, L. Edler, L.G. Hanin, A.Y. Yakovlev, Estimating the natural history of breast cancer from bivariate data on age and tumor size at diagnosis, in: L. Edler and C.P. Kitsos, (Eds.), Quantitative Methods for Cancer and Human Health Risk Assessment, Wiley, New York, pp. 317-327.
41. L.G. Hanin, L.V. Pavlova, Optimal regimens of cancer screening, in: L. Edler and C.P. Kitsos(Eds.), Quantitative Methods for Cancer and Human Health Risk Assessment, Wiley, New York, pp. 177-191.
42. van Oortmarssen G.J., Habbema J.D., Lubbe J.T., and van der Maas P.J. A model-based analysis of the HIP project for breast cancer screening. Int. J. Cancer 46 (1990) 207
43. Peer P.G., van Dijck J.A., Hendriks J.H., Holland R., and Verbeek A.L. Age-dependent growth rate of primary breast cancer. Cancer 71 (1993) 3547
44. Mandelblatt J., Saha S., Teutsch S., Hoerger T., Siu A.L., Atkins D., Klein J., and Helfand M. A systematic review for the U.S. Preventive Services Task Force: the cost-effectiveness of screening mammography beyond age 65. Ann. Intern. Med. 139 (2003) 835
45. Yakovlev A.Y., Hanin L.G., Rachev S.T., and Tsodikov A.D. A distribution of tumor size at detection and its limiting form. Proc. Nat. Acad. Sci. USA 93 (1996) 6671
46. Hanin L.G., Rachev S.T., Tsodikov A.D., and Yakovlev A.Y. A stochastic model of carcinogenesis and tumor size at detection. Adv. Appl. Prob. 29 (1997) 607
47. Tsodikov A.D., Asselain B., and Yakovlev A.Y. A distribution of tumor size at detection: an application to breast cancer data. Biometrics 53 (1997) 1495